“ipilimumab” Archives

in
Entry Author Date Location
Gilead Sciences Places $120M Bet on a Jounce Therapeutics Cancer Drug 09/01/20 San Francisco
Xilio Unveils New Name, $100M to Bring Targeted Cancer Drugs to Clinic 03/02/20 Boston
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Immunotherapy Is Now Here For Breast Cancer. What Are Its Prospects? 05/29/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo 01/24/19 New York
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
FDA’s Latest Cancer Approval Underscores Immunotherapy Nobel Prize 10/01/18 National
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer 08/17/18 New York
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down 05/31/18 National
Ahead of ASCO, Merck Touts Another Win for Lung Cancer Drug Combo 05/23/18 New York
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
With New Data, Drug Combos, Lung Cancer Experts Scramble to Keep Pace 04/11/18 National
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More 02/09/18 National
Bristol-Myers Immune Drug Combo Hits Early Mark in Lung Cancer Study 02/05/18 New York
BioCryst, Idera Plan Merger in Tie-Up of Rare Disease Drug Developers 01/22/18 Raleigh Durham
Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward 01/16/18 New York
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Bio Roundup: Frazier v. Trump, Data Dumps, New York Steps & More 08/18/17 National
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
Bio Roundup: Clinical Shirkers, AMD Worriers, ASH Fallers & More 11/04/16 National
In Immuno-Oncology’s Latest Win, FDA OK’s Genentech Drug 05/18/16 San Francisco
Cancer Vaccines Back in Vogue as VCs Put $102M Into Gritstone Oncology 10/20/15 San Francisco
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
Page 1 of 2 next page »